Search results
Is Cellectar Biosciences (NASDAQ:CLRB) In A Good Position To Deliver On Growth Plans?
Simply Wall St. via Yahoo Finance· 18 hours agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...
Is Cellectar Biosciences (CLRB) Outperforming Other Medical Stocks This Year?
Zacks via Yahoo Finance· 11 months agoThe Medical group has plenty of great stocks, but investors should always be looking for companies...
Cellectar Biosciences, Inc. (NASDAQ:CLRB): When Will It Breakeven?
Simply Wall St. via Yahoo Finance· 2 months agoWe feel now is a pretty good time to analyse Cellectar Biosciences, Inc.'s (NASDAQ:CLRB) business as...
Cellectar Biosciences' (NASDAQ:CLRB) Cash Burn Situation
Simply Wall St. via Yahoo Finance· 6 months agoJust because a business does not make any money, does not mean that the stock will go down. For...
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoCellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript March 27, 2024 Cellectar...
Will Cellectar Biosciences (NASDAQ:CLRB) Spend Its Cash Wisely?
Simply Wall St. via Yahoo Finance· 2 years agoWe can readily understand why investors are attracted to unprofitable companies. For example,...
Cellectar Biosciences Inc (CLRB) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
GuruFocus.com via Yahoo Finance· 1 week agoCash and Cash Equivalents: $40.0 million as of March 31, 2024, up from $9.6 million as of December 31, 2023. Net Proceeds: Generated $43.9 million from the exercise of warrants. Net Cash Used ...
10 Best Biotech Penny Stocks To Buy Now
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we discuss the 10 best biotech penny stocks to buy now. If you want to skip our detailed analysis of the biotech sector, go directly to...